Description
A natural phenylpropanoid glucoside; inhibits PKC (IC50 = 25 μM); inhibits the growth of Gram-positive and Gram-negative bacteria, including S. aureus and E. coli (MICs = 16 and 32 μg/ml, respectively); dose-dependently reduces extracellular hydrogen peroxide and increases cell viability of PC12 cells at 0.1-10 μg/ml following MPP+ administration to induce apoptosis and oxidative stress; dose-dependently inhibits the growth of MGC803 adenocarcinoma cells at 10-20 μM; reduces colon damage and the expression of TNF-α, IL-1β, and iNOS in a rat model of DNBS-induced colitis at 0.2-2 mg/kg,
Formal name: 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
Synonyms: Acteoside|NSC 603831
Molecular weight: 624.6
CAS: 61276-17-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Kinase Inhibitors|PKC||Product Type|Biochemicals|Natural Products|Glycosides||Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer||Research Area|Immunology & Inflammation|Gastric Disease|Crohn’s Disease||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen
